Drug Approval | August 06, 2023
Eugia Pharma receives USFDA approval for Vancomycin Hydrochloride for Injection USP
The product is being launched in August 2023
The product is being launched in August 2023
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
The joint venture will help both the parties to further develop the high-margin service business
The CRL did not identify any outstanding scientific issues with the product.
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of US $282 million in the US
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
Clobetasol Propionate Foam, 0.05% has an estimated market size of US $ IO million for twelve months ending Dec 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated
